Literature DB >> 11071695

Variability of pressure-flow studies in men with lower urinary tract symptoms.

G S Sonke1, B B Kortmann, A L Verbeek, L A Kiemeney, F M Debruyne, J J de La Rosette.   

Abstract

The objective of this study was to assess the short-term test-retest variability of pressure-flow studies (PFS) in men with lower urinary tract symptoms (LUTS). By choosing a short interval between two consecutive PFS, but notably not performing two tests within a single session, both tests represent the same routine testing procedure. Eighty-nine patients with LUTS suggestive of bladder outlet obstruction or detrusor underactivity, who received PFS, were asked to undergo a second urodynamic evaluation within 4 weeks after the initial test. At both visits, specialized physicians performed the PFS. Obstruction was quantified using the Abrams-Griffiths number (AG number). Each patient was classified as obstructed, unobstructed, or equivocally obstructed according to the International Continence Society nomogram. As expected, no systematic difference was observed in AG number between the first and the second visit at the group level. There was, however, considerable variation at the individual level. The average within-patient standard deviation was 14 cm H(2)O. This finding shows that if a patient's AG number is 30 at the first visit, his true AG number can be any value between 30 +/- 1.96 * 14 = 3 to 57, owing to random variability alone. The average within-patient standard deviation did not differ significantly between sub-groups of obstruction and other variables such as patient age, symptom score, prostate volume, or residual volume. The variability appeared to increase slightly with an increased interval between visits. Of all patients, 39% changed at least one category of obstruction at the second visit and 3% changed from definitely obstructed to definitely unobstructed or vice versa. We conclude that PFS cannot stand the test of serving as a gold standard to identify bladder outlet obstruction in patients with LUTS.

Entities:  

Mesh:

Year:  2000        PMID: 11071695     DOI: 10.1002/1520-6777(2000)19:6<637::aid-nau2>3.0.co;2-w

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  5 in total

1.  [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].

Authors:  K Höfner; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; T Bschleipfer
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

Review 2.  The role of invasive and non-invasive urodynamics in male voiding lower urinary tract symptoms.

Authors:  Brian A Parsons; Elizabeth Bright; Ahmed M Shaban; Anne Whitehouse; Marcus J Drake
Journal:  World J Urol       Date:  2009-11-15       Impact factor: 4.226

Review 3.  The role of urodynamics in the diagnosis and treatment of benign prostatic hyperplasia.

Authors:  J Quentin Clemens
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

Review 4.  Urological management of the patient with traumatic spinal cord injury.

Authors:  C Persu; V Caun; I Dragomiriţeanu; P Geavlete
Journal:  J Med Life       Date:  2009 Jul-Sep

5.  Clinical evaluation of a simple uroflowmeter for categorization of maximum urinary flow rate.

Authors:  Simon Pridgeon; Christopher Harding; Douglas Newton; Robert Pickard
Journal:  Indian J Urol       Date:  2007-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.